Literature DB >> 23115435

Nosocomial infections: the definition criteria.

Farideh Kouchak1, Mehrdad Askarian.   

Abstract

Entities:  

Year:  2012        PMID: 23115435      PMCID: PMC3470069     

Source DB:  PubMed          Journal:  Iran J Med Sci        ISSN: 0253-0716


× No keyword cloud information.
In 1988, the Centers for Disease Control and Prevention (CDC) published two articles on nosocomial infections (NIs) and certain types of NIs’ criteria for surveillance purposes. Nosocomial infections refer to any systemic or localized conditions that result from the reaction by an infectious agent or toxin.[1] The infection is developing in all high, middle and low income countries. The CDC estimated that the cost of events related to NIs was an average of $2,100, and varied from $680 for urinary tract infections to $5,683 for respiratory tract infections in the United States of America.[2] An intensive care unit (ICU) is one of the hospital wards critical in the treatment of many serious diseases, which needs particular cares. Despite having a prominent role in the care of patients with infections, ICUs cause some complications and death, and increases the costs imposed on patients and society.[3] The incidence of NIs related to mechanical ventilation, catheter insertion and some invasive procedures are more than that in other hospital wards, which do not carry such procedures.[4] Classification of NIs is critical for any surveillance program. Traditionally, a time cut-off of 48 hours after admission is used to differentiate between hospital and community acquired infections. However such a cut-off point does not present the patients’ carrier status that can cause the infection. In an attempt to solve the problem, a classification based on pathogenesis of infection and the criteria for carrier status were offered.[5] Three types of infections in ICUs including primary and secondary endogenous, and exogenous infections are defined by carrier status. Only, secondary endogenous and exogenous infections are real infections acquired in ICUs.[6] The overall incidence of NIs is 6.1% to 29.6% in pediatric ICUs. Using the CDC definition of NIs, which is defined as infection occurring 48 hours after admission, it was shown that in a sample of 1239 pediatric patients in 2009 the incidence of NIs was 24.5 per 1000 person days, and that the length of stay of patients with NI in ICU was higher than that without the infection.[7] Overall, many studies have focused on the epidemiology, risk factors, and prevention methods in adults patients. However, there have been limited studies on NI in pediatric patients.[2] The current issue of Iranian Journal of Medical Sciences publishes a paper by Jiří Žurek, and Michal Fedora titled “classification of infections in intensive care units: A comparison of current definition of hospital-acquired infections and carrier state criterion.” The paper compares the classification of NI based the CDC definition of the infection and carrier state criterion. The article is highly important in showing the two definitions of NIs. However, the use of each of the definitions in surveillance programs can cause confusion. Lacking a widely-accepted standard definition for infections, such as nosocomial infections, can lead physicians to incorrect diagnosis and treatment of infections. The first study about hospital infection in ICUs in Iran showed that for correct comparison and control of hospital infections, we need to use international standards in population of study,[8] to be able to have correct comparisons and plans to control infections. In addition, it is better that the cut-off time and carrier status of admitted patients are compared in several aspects including diagnosis, burdens of diseases in the community, health care workers’ concern about the origin of infection, various precautions and use of various diagnostic techniques. Nosocomial infections is over estimated in the cut-off time definition and underestimated in carrier state definition protocol. If comparison of different classification methods could be accompanied with a strong research design and analysis, additional financial and psychological costs could be reduced.
  7 in total

1.  Are most ICU infections really nosocomial? A prospective observational cohort study in mechanically ventilated patients.

Authors:  L Silvestri; C Monti Bragadin; M Milanese; D Gregori; C Consales; A Gullo; H K van Saene
Journal:  J Hosp Infect       Date:  1999-06       Impact factor: 3.926

2.  Nosocomial infection rates following cardiothoracic surgery in Iran.

Authors:  Mehrdad Askarian; Craig Williams; Ojan Assadian
Journal:  Int J Infect Dis       Date:  2005-11-18       Impact factor: 3.623

3.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.

Authors:  Teresa C Horan; Mary Andrus; Margaret A Dudeck
Journal:  Am J Infect Control       Date:  2008-06       Impact factor: 2.918

4.  Prevalent bacterial infections in intensive care units of Shiraz University of medical sciences teaching hospitals, Shiraz, Iran.

Authors:  Parvin Hassanzadeh; Mohammad Motamedifar; Nahal Hadi
Journal:  Jpn J Infect Dis       Date:  2009-07       Impact factor: 1.362

5.  Classification and risk-factor analysis of infections in a surgical neonatal unit.

Authors:  K R Shankar; D Brown; J Hughes; G L Lamont; P D Losty; D A Lloyd; H K van Saene
Journal:  J Pediatr Surg       Date:  2001-02       Impact factor: 2.545

6.  Nosocomial infection in a pediatric intensive care unit in a developing country.

Authors:  Marcelo L Abramczyk; Werther B Carvalho; Eduardo S Carvalho; Eduardo A S Medeiros
Journal:  Braz J Infect Dis       Date:  2004-03-01       Impact factor: 1.949

7.  Nosocomial infections in the pediatric intensive care units in Lithuania.

Authors:  Jolanta Asembergiene; Vaidotas Gurskis; Rimantas Kevalas; Rolanda Valinteliene
Journal:  Medicina (Kaunas)       Date:  2009       Impact factor: 2.430

  7 in total
  5 in total

1.  Biofilm Inhibitor Taurolithocholic Acid Alters Colony Morphology, Specialized Metabolism, and Virulence of Pseudomonas aeruginosa.

Authors:  Alanna R Condren; Lisa Juliane Kahl; Gabriela Boelter; George Kritikos; Manuel Banzhaf; Lars E P Dietrich; Laura M Sanchez
Journal:  ACS Infect Dis       Date:  2020-01-03       Impact factor: 5.084

2.  Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART).

Authors:  Alfredo Ponce-de-Leon; Eduardo Rodríguez-Noriega; Rayo Morfín-Otero; Dora P Cornejo-Juárez; Juan C Tinoco; Areli Martínez-Gamboa; Carmen J Gaona-Tapia; M Lourdes Guerrero-Almeida; Alexandra Martin-Onraët; José Luis Vallejo Cervantes; José Sifuentes-Osornio
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

3.  Pan drug-resistant Acinetobacter baumannii causing nosocomial infections among burnt children.

Authors:  Behnam Sobouti; Maryam Mirshekar; Shahrzad Fallah; Aram Tabaei; Jalil Fallah Mehrabadi; Atieh Darbandi
Journal:  Med J Islam Repub Iran       Date:  2020-03-23

4.  Comparative Structure-Activity Analysis of the Antimicrobial Activity, Cytotoxicity, and Mechanism of Action of the Fungal Cyclohexadepsipeptides Enniatins and Beauvericin.

Authors:  Hamza Olleik; Cendrine Nicoletti; Mickael Lafond; Elise Courvoisier-Dezord; Peiwen Xue; Akram Hijazi; Elias Baydoun; Josette Perrier; Marc Maresca
Journal:  Toxins (Basel)       Date:  2019-09-03       Impact factor: 4.546

5.  Evaluation of antibiotic susceptibility patterns of pathogens isolated from routine laboratory specimens at Ndola Teaching Hospital: A retrospective study.

Authors:  Warren Chanda; Mespa Manyepa; Ephraim Chikwanda; Victor Daka; Justin Chileshe; Mathias Tembo; Joseph Kasongo; Allen Chipipa; Ray Handema; John A Mulemena
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.